[Action of anti-arrhythmic beta-blockaders].
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D001001:Anura; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000188:drug therapy*; D005117:Cardiac Complexes, Premature / Q000188:drug therapy; D002395:Catecholamines / Q000009:adverse effects; D002415:Cats; D002462:Cell Membrane / Q000187:drug effects; D004071:Digitalis Glycosides / Q000009:adverse effects; D006168:Guinea Pigs; D006329:Heart Conduction System / Q000187:drug effects; D006801:Humans; D011217:Practolol / Q000494:pharmacology / Q000627:therapeutic use; D011342:Procainamide / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011690:Purkinje Fibers / Q000187:drug effects; D011802:Quinidine / Q000494:pharmacology; D011817:Rabbits
D000319:Adrenergic beta-Antagonists; D002395:Catecholamines; D004071:Digitalis Glycosides; D011433:Propranolol; D011802:Quinidine; D011342:Procainamide; D011217:Practolol